Articles

Sort by
Previous Page Page 2 of 10 Next Page
  1. Research

    Information, regulation and coordination: realist analysis of the efforts of community health committees to limit informal health care providers in Nigeria

    One of the consequences of ineffective governments is that they leave space for unlicensed and unregulated informal providers without formal training to deliver a large proportion of health services. Without i...

    Seye Abimbola, Kemi Ogunsina, Augustina N. Charles-Okoli, Joel Negin, Alexandra L. Martiniuk and Stephen Jan

    Health Economics Review 2016 6:51

    Published on: 14 November 2016

  2. Research

    Measuring patients’ priorities using the Analytic Hierarchy Process in comparison with Best-Worst-Scaling and rating cards: methodological aspects and ranking tasks

    Identifying patient priorities and preference measurements have gained importance as patients claim a more active role in health care decision making. Due to the variety of existing methods, it is challenging ...

    Katharina Schmidt, Ana Babac, Frédéric Pauer, Kathrin Damm and J-Matthias von der Schulenburg

    Health Economics Review 2016 6:50

    Published on: 14 November 2016

  3. Research

    Design and implementation of community engagement interventions towards healthcare quality improvement in Ghana: a methodological approach

    Nearly four decades after the Alma-Ata declaration of 1978 on the need for active client/community participation in healthcare, not much has been achieved in this regard particularly in resource constrained co...

    Robert Kaba Alhassan, Edward Nketiah-Amponsah and Daniel Kojo Arhinful

    Health Economics Review 2016 6:49

    Published on: 26 October 2016

  4. Research

    Comparison of post-authorisation measures from regulatory authorities with additional evidence requirements from the HTA body in Germany – are additional data requirements by the Federal Joint Committee justified?

    The aim of this study was to compare post-authorisation measures (PAMs) from the European Medicines Agency (EMA) with data requests in fixed-termed conditional appraisals of early benefit assessments from the ...

    Jörg Ruof, Thomas Staab, Charalabos-Markos Dintsios, Jakob Schröter and Friedrich Wilhelm Schwartz

    Health Economics Review 2016 6:46

    Published on: 29 September 2016

  5. Research

    Utilization of healthcare services and renewal of health insurance membership: evidence of adverse selection in Ghana

    Utilization of healthcare in Ghana’s novel National Health Insurance Scheme (NHIS) has been increasing since inception with associated high claims bill which threatens the scheme’s financial sustainability. Th...

    Stephen Kwasi Opoku Duku, Francis Asenso-Boadi, Edward Nketiah-Amponsah and Daniel Kojo Arhinful

    Health Economics Review 2016 6:43

    Published on: 13 September 2016

  6. Research

    Frontline staff motivation levels and health care quality in rural and urban primary health facilities: a baseline study in the Greater Accra and Western regions of Ghana

    The population of Ghana is increasingly becoming urbanized with about 70 % of the estimated 26.9 million people living in urban and peri-urban areas. Nonetheless, eight out of the ten regions in Ghana remain p...

    Robert Kaba Alhassan and Edward Nketiah-Amponsah

    Health Economics Review 2016 6:39

    Published on: 31 August 2016

  7. Research

    Revisiting the child health-wealth nexus

    The causal link between a household’s economic standing and child health is known to suffer from endogeneity. While past studies have exemplified the causal link to be small, albeit statistically significant, ...

    Adnan M. S. Fakir

    Health Economics Review 2016 6:38

    Published on: 30 August 2016

  8. Research

    Patient preferences in allergy immunotherapy (AIT) in Germany – a discrete-choice-experiment

    Allergic Rhinitis (AR) is a common disorder in Europe with Allergic Asthma (AA) as a frequent comorbidity. Allergy immunotherapy (AIT) is the only causal therapy of AR and AA, and can be administered as subcut...

    Kathrin Damm, Janina Volk, Andreas Horn, Jean-Pierre Allam, Ninette Troensegaard-Petersen, Niels Serup-Hansen, Thomas Winkler, Ivonne Thiessen, Kathrin Borchert, Eike G. Wüstenberg and Thomas Mittendorf

    Health Economics Review 2016 6:32

    Published on: 2 August 2016

  9. Research

    Benefit assessment in Germany: implications for price discounts

    The AMNOG regulation, introduced in 2011 in Germany, changed the game for new drugs. Now, the industry is required to submit a dossier to the GBA (the central decision body in the German sickness fund system) ...

    Ulrike Theidel and J-Matthias Graf von der Schulenburg

    Health Economics Review 2016 6:33

    Published on: 2 August 2016

  10. Research

    Health system support and health system strengthening: two key facilitators to the implementation of ambulatory tuberculosis treatment in Uzbekistan

    Uzbekistan inherited a hospital-based health system from the Soviet Union. We explore the health system-related challenges faced during the scale-up of ambulatory (outpatient) treatment for drug-susceptible an...

    Stefan Kohler, Damin Abdurakhimovich Asadov, Andreas Bründer, Sean Healy, Atadjan Karimovich Khamraev, Natalia Sergeeva and Peter Tinnemann

    Health Economics Review 2016 6:28

    Published on: 12 July 2016

Previous Page Page 2 of 10 Next Page